An analysis of 843 studies found that drinking less than one alcoholic beverage daily is associated with elevated cancer risks, raising questions about federal dietary guidelines that recently eliminated specific daily alcohol limits.
By yourNEWS Media Newsroom
SEATTLE — Even modest alcohol consumption increases the risk of several cancers, including breast and colorectal cancer, according to a comprehensive scientific review that found no risk-free level of drinking for cancer and identified adverse health associations across all 20 conditions examined at high levels of consumption.
The study published June 1 in Nature Health was conducted by researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME). It analyzed 843 observational studies published between 1961 and 2023, drawing on 16 systematic reviews across four research databases to evaluate the relationship between alcohol consumption and major health conditions.
Researchers found increased risks associated with alcohol consumption for all 10 cancers examined, including cancers of the breast, colorectum, esophagus, larynx, mouth, pharynx, liver, stomach, pancreas and prostate. For nine of those cancers, increased risk was evident even at consumption levels below 10 grams of pure alcohol daily, equivalent to approximately two-thirds of a standard American alcoholic drink.
The findings challenge the longstanding perception that moderate drinking, particularly red wine consumption, provides meaningful health benefits without significant risks.
“For cancer, the evidence is consistent and unambiguous: risk rises with any level of alcohol intake,” said Dr. Emmanuela Gakidou, the study’s senior author and a professor of health metrics sciences at IHME.
The strongest association involved pharyngeal cancer, which affects the throat. Researchers identified at least a 105% increase in relative risk at average alcohol consumption levels, meaning the estimated risk was more than double that of the comparison group.
Cancers of the larynx, colorectum, lip and oral cavity were associated with relative risk increases ranging from at least 22% to 49%. The analysis also identified elevated risks for breast, liver, pancreatic, esophageal and prostate cancers, although the strength of evidence varied among those conditions.
The researchers used a statistical method known as the Burden of Proof framework, which accounts for differences in study design, potential biases and uncertainty when estimating health risks.
The framework produces conservative estimates intended to represent the smallest plausible health effects supported by the available evidence. Consequently, the reported increases should not necessarily be interpreted as the maximum risks associated with alcohol consumption.
The percentages represent changes in relative risk rather than absolute probability. A doubling of relative risk, for example, does not mean that half of people who consume alcohol will develop the disease.
According to additional findings released by IHME, evidence linking alcohol to pharyngeal cancer was particularly strong, while the associations with other cancers varied in certainty.
The findings are significant because public awareness of alcohol’s association with breast and colorectal cancer remains relatively low, despite both diseases accounting for substantial numbers of cancer diagnoses worldwide.
Beyond cancer, the researchers examined alcohol’s relationship with liver disease, pancreatitis, respiratory infections, tuberculosis, cardiovascular disease, Type 2 diabetes and neurological disorders.
Higher levels of alcohol consumption were associated with increased risks across all 20 outcomes examined. The analysis found that heavy drinking was consistently associated with worse health outcomes, regardless of whether some conditions showed different patterns at lower intake levels.
Alcohol consumption was also associated with increased risks of cirrhosis and other chronic liver diseases, pancreatitis and atrial fibrillation, an irregular heart rhythm that can increase the likelihood of stroke and other cardiovascular complications.
The study identified at least a 6% increase in the relative risk of atrial fibrillation and flutter at average consumption levels.
Researchers also reported associations between alcohol use and increased risks of lower respiratory infections and tuberculosis, although the evidence supporting those relationships was less conclusive than the findings involving several cancers.
The analysis produced a more complicated picture for certain cardiovascular, metabolic and neurological conditions.
Low-to-moderate alcohol consumption was associated with a modest reduction in the risk of Type 2 diabetes, estimated at a minimum of 4.5%, while Alzheimer’s disease and other dementias showed an association with at least a 6.4% reduction.
However, the researchers cautioned that these findings do not establish that alcohol consumption directly protects against either condition.
The studies were observational, meaning they identified statistical relationships between drinking habits and health outcomes without demonstrating that alcohol itself caused the apparent benefits.
Differences in diet, physical activity, socioeconomic status, smoking history and other lifestyle factors can influence results. Comparisons between drinkers and nondrinkers may also be affected by whether the nondrinking group includes former heavy drinkers or individuals who stopped consuming alcohol because of existing health problems.
The evidence for potential protection against ischemic heart disease and stroke was particularly inconsistent.
Some studies suggested modest benefits from light drinking, while others found little evidence of protection. At higher consumption levels, the risk of heart disease and both ischemic and hemorrhagic stroke increased.
The researchers emphasized that the apparent benefits for some conditions should not be treated as a reason to begin drinking.
“Our findings should not be interpreted as endorsing alcohol consumption for health benefits,” the study authors cautioned.
Gakidou said the findings demonstrate why alcohol consumption cannot be evaluated through a single health outcome. Although the evidence involving some metabolic and neurological conditions remains mixed, the cancer findings consistently associate drinking with increased risk.
The research also raised questions about public health recommendations, particularly following changes to federal dietary guidelines earlier this year.
In January, the Trump administration released the 2025-2030 Dietary Guidelines for Americans, replacing previous recommendations that men consume no more than two alcoholic drinks daily and women no more than one.
The revised guidelines instead advise Americans to consume less alcohol for better overall health without establishing specific daily numerical limits.
According to Reuters reporting on the January announcement, the changes eliminated longstanding sex-specific recommendations and prompted debate over whether the government was providing sufficiently clear information about alcohol-related health risks.
The revised guidelines do not explicitly address alcohol’s relationship with cancer in their brief recommendations concerning drinking.
At the White House briefing announcing the changes, Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, described alcohol as a “social lubricant” that can help people connect socially.
Oz also acknowledged that abstaining from alcohol is preferable from a health standpoint, saying, “in the best case scenario, I don’t think that you should drink alcohol.”
The Associated Press reported that federal officials defended the updated recommendations as part of a broader effort to improve Americans’ diets and reduce consumption of unhealthy products.
Critics argued that eliminating specific consumption limits could make it more difficult for the public to understand the differences between low-risk drinking patterns and those associated with substantially greater health risks.
Mike Marshall, CEO of the U.S. Alcohol Policy Alliance, criticized the revised federal guidance and called for clearer communication about alcohol’s health consequences.
The public “deserves clear, honest information about the risks of drinking so they can make the best decisions for themselves, their families, and their communities,” Marshall said.
The University of Washington researchers also examined the considerable differences among alcohol guidelines internationally.
Recommended daily limits in existing guidelines ranged from approximately 8 to 42 grams of alcohol for women and 10 to 52 grams for men, demonstrating substantial disagreement over what constitutes acceptable consumption.
The researchers did not identify consistent evidence supporting separate alcohol consumption thresholds for men and women across the health outcomes examined.
They also concluded that no single daily consumption threshold could be established as universally optimal for health across different populations, ages and medical conditions.
The findings do not mean that every individual who consumes alcohol will develop cancer or another serious illness. Instead, they indicate that the likelihood of certain diseases rises with alcohol exposure, including at consumption levels traditionally considered moderate.
A standard alcoholic drink in the United States contains approximately 14 grams of pure alcohol, equivalent to a 12-ounce beer containing 5% alcohol, a 5-ounce glass of wine containing 12% alcohol or 1.5 ounces of 80-proof distilled spirits.
The study’s identification of elevated cancer risks below 10 grams daily means that some measurable associations appeared at levels lower than a single standard drink.
The findings also distinguish between the absence of a demonstrated safe threshold and the magnitude of risk. Although low consumption was associated with increased cancer risk, the absolute risk for an individual depends on additional factors, including age, health history, genetics and other exposures.
The study’s methodology and conclusions, indexed by the National Library of Medicine, provide one of the most extensive evaluations of alcohol’s relationship with chronic disease using a consistent statistical framework.
Researchers said the results support public health messaging that communicates the risks of even low-to-moderate consumption while acknowledging uncertainty about some potential benefits identified in observational studies.
The analysis also reinforces the need to distinguish between claims that alcohol may be associated with certain favorable health outcomes and evidence that drinking is beneficial overall.
For consumers, the central finding is that alcohol-related cancer risk begins at levels below one standard drink per day, while heavier drinking is associated with increased risks across every health outcome examined.
The research adds to growing scientific evidence challenging earlier public perceptions of moderate drinking as a health-promoting habit and raises further questions about whether existing government guidelines adequately communicate alcohol’s long-term risks.
Original article
Comments